immunotherapy

You have access
Prognostic value of bone marrow metabolism on pretreatment ¹⁸F-FDG PET/CT in patients with metastatic melanoma treated with anti-PD-1 therapy
Ryusuke Nakamoto, Lisa C. Zaba, Tie Liang, Sunil Arani Reddy, Guido Davidzon, Carina Mari Aparici, Judy Nguyen, Farshad Moradi, Andrei Iagaru and Benjamin Lewis Franc

Journal of Nuclear Medicine February 5, 2021, jnumed.120.254482; DOI: https://doi.org/10.2967/jnumed.120.254482
You have access
Immune-Checkpoint Blockade Enhances ²²⁵Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer
Johannes Czernin, Kyle Current, Christine E. Mona, Lea Nyiranshuti, Firas Hikmat, Caius G. Radu and Katharina Lückerath

Journal of Nuclear Medicine February 1, 2021, 62 (2) 228-231; DOI: https://doi.org/10.2967/jnumed.120.246041
You have access
Development and Evaluation of Interleukin-2–Derived Radiotracers for PET Imaging of T Cells in Mice
Elly L. van der Veen, Frans V. Suurs, Frederik Cleeren, Guy Bormans, Philip H. Elsinga, Geke A.P. Hospers, Marjolijn N. Lub-de Hooge, Elisabeth G.E. de Vries, Erik F.J. de Vries and Inês F. Antunes

Journal of Nuclear Medicine September 1, 2020, 61 (9) 1355-1360; DOI: https://doi.org/10.2967/jnumed.119.238782
You have access
Imaging the Cancer Immune Environment and Its Response to Pharmacologic Intervention, Part 1: The Role of ¹⁸F-FDG PET/CT
Amir Iravani and Rodney J. Hicks

Journal of Nuclear Medicine July 1, 2020, 61 (7) 943-950; DOI: https://doi.org/10.2967/jnumed.119.234278
You have access
Early ¹⁸F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with Nivolumab
Aiping Chen, Fatima-Zohra Mokrane, Lawrence H. Schwartz, Franck Morschhauser, Apasia Stamatoullas, Jean-Marc Schiano de Colella, Laetitia Vercellino, Olivier Casasnovas, Adrien Chauchet, Alain Delmer, Emmanuelle Nicolas-Virelizier, Hervé Ghesquières, Marie-Pierre Moles-Moreau, Anna Schmitt, Rémy Dulery, Krimo Bouabdallah, Cecile Borel, Mohamed Touati, Benedicte Deau-Fischer, Frédéric Peyrade, Romain-David Seban, Guillaume Manson, Philippe Armand, Roch Houot and Laurent Dercle

Journal of Nuclear Medicine May 1, 2020, 61 (5) 649-654; DOI: https://doi.org/10.2967/jnumed.119.232827
Open Access
An ⁸⁹Zr-HDL PET Tracer Monitors Response to a CSF1R Inhibitor
Christian A. Mason, Susanne Kossatz, Lukas M. Carter, Giacomo Pirovano, Christian Brand, Navjot Guru, Carlos Pérez-Medina, Jason S. Lewis, Willem J.M. Mulder and Thomas Reiner

Journal of Nuclear Medicine March 1, 2020, 61 (3) 433-436; DOI: https://doi.org/10.2967/jnumed.119.230466
You have access
The Immunoimaging Toolbox
Aaron T. Mayer and Sanjiv S. Gambhir

Journal of Nuclear Medicine August 1, 2018, 59 (8) 1174-1182; DOI: https://doi.org/10.2967/jnumed.116.185967
You have access
Immune Modulation Therapy and Imaging: Workshop Report
Anthony F. Shields, Paula M. Jacobs, Mario Sznol, Michael M. Graham, Ron N. Germain, Lawrence G. Lum, Elizabeth M. Jaffee, Elisabeth G.E. de Vries, Sridhar Nimmagadda, Annick D. Van den Abbeele, David K. Leung, Anna M. Wu, Elad Sharon and Lalitha K. Shankar

Journal of Nuclear Medicine March 1, 2018, 59 (3) 410-417; DOI: https://doi.org/10.2967/jnumed.117.195610
You have access
CXCR4 Ligands: The Next Big Hit?
Annemiek M.E. Walenkamp, Constantin Lapa, Ken Herrmann and Hans-Jürgen Wester

Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 77S-82S; DOI: https://doi.org/10.2967/jnumed.116.186874
You have access
Molecular Imaging of Immunotherapy Targets in Cancer
Emily B. Ehlerding, Christopher G. England, Douglas G. McNeel and Weibo Cai

Journal of Nuclear Medicine October 1, 2016, 57 (10) 1487-1492; DOI: https://doi.org/10.2967/jnumed.116.177493

Main menu

User menu

Search

immunotherapy

Pages